Experts present the results of a retrospective analysis of patients who received IV ketamine for TRD over a timeframe of up to 2 years.
In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.
In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.
Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.
How can Ibogaine help patients with Alcohol Use Disorder, specifically in veterans?
In this CME article, learn how best to provide end-of-life care to patients with psychiatric disorders.
Devoting funds to better benefit brain health could improve society as a whole.
For psychiatrists, can a poorly made film contain themes worthy of analysis?
COVID-19 has prompted an unprecedented shift toward virtual psychiatric health care—but how do patients and providers really feel about it?
Emergency departments face unique challenges in providing psychiatric care for individuals with intellectual and developmental disabilities, impacting wait times and overall experience.
Here's how medical practitioners and researchers can influence AI reasoning and influence in the future of AI development and deployment.
It’s time to address adult ADHD.
In approximately half of patients with Huntington disease, symptoms of depression, irritability/aggression, executive dysfunction, psychosis, cognitive decline, and dementia present long before progressive motor symptoms.
Learn more about a feasible, scalable, effective model of care that is a step away from the forced dichotomy of inpatient and outpatient care.
Shahriar SheikhBahaei, PhD, discusses how animal models may lead to better treatments.
Just because a patient has anxiety or past trauma does not mean they cannot enjoy this spooky holiday…
A nurse practitioner discusses author James Baldwin and the importance of moving from fear toward self-advocacy and self-love.
Early phase 3 results show that a single dose of MM120 can rapidly reduce anxiety symptoms in GAD patients, with effects lasting up to 12 weeks.
The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.
In this CME article, learn more about the common neuropsychiatric sequelae of post-acute sequelae of COVID-19, the underlying neurobiological mechanisms, and evidence-based treatments and interventions.
Misinformation and disinformation are widespread and having adverse effects on individuals’ health decisions. How can we address the problem?
In this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.
PME affects many women, yet it remains under-recognized in clinical practice and in research.
How can we support loved ones who are suffering from addiction?
Check out these insights from clinicians at Real Psychiatry!
Politics have gotten in the way of mask-wearing, and they should not.